Trials / Completed
CompletedNCT06695598
Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy Volunteers
An Open Label, Randomized, Single Dose, Crossover, Phase I Study to Evaluate the Effects of Food on Pharmacokinetics and the Safety of CKD-383 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study is a randomized, open-label, single dose, crossover study to evaluate the food effect of CKD-383 in healthy volunteers
Detailed description
To 30 healthy subjects, following treatments are administered dosing in each period and wash-out period is 7 days
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-383 | QD, PO |
Timeline
- Start date
- 2024-11-06
- Primary completion
- 2024-12-08
- Completion
- 2024-12-19
- First posted
- 2024-11-19
- Last updated
- 2025-05-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06695598. Inclusion in this directory is not an endorsement.